SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of American Renal Associates Holdings, Inc.
NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces it has commenced an investigation of American Renal Associates Holdings, Inc. (“ARA” or “the Company”) (NYSE: ARA) concerning possible violations of federal securities laws.
On March 8, 2019, ARA filed a notification of inability to timely file its Form 10-K for the fiscal year, and disclosed a request from the U.S. Securities and Exchange Commission, seeking information relating to the Company’s revenue recognition, collections, and related matters. On March 27, 2019, ARA Filed an 8-K for non-reliance on previously issued financial statements and restatement of financial data. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com